← Back to All Filings

ARTV CTO Sells $6.2k in Stock to Cover Tax Obligations

Low SignificanceNovember 17, 2025 at 9:02:10 PM EST

Artiva Biotherapeutics, Inc.

$ARTV4CIK: 0001817241

Subscribe to track ARTV

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

ARTV CTO Sells $6.2k in Stock to Cover Tax Obligations

Company: Artiva Biotherapeutics, Inc. (ARTV) Form: 4 | Filed: 2025-11-17 Significance: Low

Insider: Horan Christopher Title: Chief Tech Operations Officer | Relationship: Officer

Transaction: • Type: Tax Withholding • Shares: 1,899 • Price: $3.25 • Value: $6,172 • Owned After: 78,183

Key Insight: This is a routine "sell-to-cover" transaction to satisfy tax liabilities from vested stock units, not a discretionary sale by the insider.

Market Context: The transaction value is negligible, representing only ~0.008% of the company's $80 million market capitalization.

View Full Filing

This is PUBLIC SEC data for educational purposes. Not investment advice.

Comprehensive Analysis

SEC Filing Analysis: Artiva Biotherapeutics, Inc. (ARTV)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: The Chief Technical Operations Officer disposed of shares in a non-discretionary transaction to cover tax obligations related to vested stock units.
  • Market Impact: Neutral. This type of transaction is routine and does not signal a change in insider sentiment.

Company Information

FieldValue
CompanyArtiva Biotherapeutics, Inc.
Ticker SymbolARTV
CIK0001817241
IndustryBIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)

Insider Information

FieldValue
NameHoran Christopher
CIK0001736819
Title/PositionChief Tech Operations Officer
RelationshipOfficer

Transaction Details

FieldValue
Form Type4
Transaction Date2025-11-15
Transaction CodeF (Withholding of securities for tax liability)
Security TypeCommon Stock
Shares Involved1,899
Price Per Share$3.25
Total Value$6,171.75
Shares Owned After78,183
Ownership TypeDirect

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$6,171.75
% of Market Cap0.0077%
Shares Transacted1,899
% of Shares OutstandingNot Available
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: The transaction value of approximately $6.2k is insignificant relative to Artiva's $80 million market capitalization.
  • Transaction Significance: The transaction is classified as low significance due to its negligible value and its nature as an automatic withholding to cover taxes, not a deliberate market sale by the insider.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: The transaction was a pre-arranged, non-discretionary sale to cover tax liabilities associated with vested restricted stock units. It does not reflect the insider's current market sentiment.

Volume & Sentiment

  • Expected Volume Impact: Negligible. The number of shares is too small to impact trading volume.
  • Sentiment Indicator: Neutral. This is a routine corporate action, not an investment decision.

Additional Context

Transaction Notes

  • Special Circumstances: The filing's footnote confirms the shares were withheld by the issuer to satisfy tax obligations from the vesting of restricted stock units. This is a common and non-indicative transaction.
Topics:#SECFiling#InsiderTrading#ARTV#ArtivaBiotherapeutics#Form4#SellToCover#StockMarket#Investing

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.